Permira IV realises 3.2x return in Pharmaq sale
The firm acquired Pharmaq in 2013 for about €250m and is selling it to Zoetis for $765m.
The firm acquired Pharmaq in 2013 for about €250m and is selling it to Zoetis for $765m.
Copyright PEI Media
Not for publication, email or dissemination